Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment
The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Business Wire20h
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
Precision Medicine Online22h
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.